Xcene Research is a leading indigenous African Contract Research Organization (CRO) providing full-service support to pharmaceutical, biotechnology, and medical device companies, as well as academic institutions.

We offer a range of services that help companies take new products from discovery through to market, with a specific focus on emerging markets across Sub-Saharan Africa. Our expertise spans the management, execution, and analysis of clinical trials from Phase I through Phase IV, covering both small-scale and complex global programs and bioavailability/bioequivalence studies.

In addition to our CRO capabilities, Xcene Research is actively engaged in Drug Discovery, supporting early-stage research, preclinical studies, and translational research. This dual capability allows us to provide end-to-end R&D services, positioning Africa as a contributor to global health innovation and ensuring that therapies are relevant to the continent’s unique disease burdens.

Trust is one of our core values. We uphold it through on-time delivery, uncompromising quality, transparent communication, and complete visibility into project status. These values guide our interactions with sponsors, regulators, and health communities alike.

As a pioneer in the Sub-Saharan African market, Xcene Research combines therapeutic expertise, internal capacity, and financial stability to deliver cost-effective, world-class services.

Headquartered in Lagos, Nigeria, we are committed to building strategic partnerships worldwide and advancing Africa’s role in global clinical research and drug innovation.

Our Mission

Xcene Research’s mission is to be a catalyst for accelerated access to life-saving treatments in Africa.

Our Vision

We foresee more complex medical breakthroughs ahead with us at the helm, providing clinical solutions at each stage of the way.

Our Core Values

At Xcene, our patients come first, always. We believe that true success is measured not just by clinical achievements, but by the health, safety, and informed participation of our patients, the strength of families, and our commitment to serving humanity through responsible and ethical research.

Grounded in fairness and justice, our commitment to equity drives us to ensure diverse and inclusive access to clinical trials, creating an environment where every patient population feels seen, heard, and is represented in the development of future medicines. Knowing that today’s choices shape tomorrow’s world, we actively nurture a workplace that celebrates diverse perspectives, prioritizes inclusion, and leads with integrity and empathy.

United by purpose, we pursue meaningful care, connection, and scientific progress, building a legacy defined by the lives we uplift and the life-changing treatments we help bring to the world.